Drs. Mark A. Wainberg and Daniel R. Kuritzkes guide clinicians through antiretroviral drug resistance testing and the latest data on resistance to new antiretroviral classes and novel therapeutics. Medscape HIV/AIDS
Drs. Daar, Haubrich, and Walmsley discuss the progress of antiretroviral therapy at 2008 HIV Management: The New York Course, held April 25-26, 2008, in New York, NY. Medscape HIV/AIDS
Drs. Bartlett and Hirsch discuss perspectives and controversies of HIV management at the 2008 HIV Management: The New York Course, held April 25-26, 2008, in New York. Medscape HIV/AIDS
Drs. Lederman and Herold review HIV pathogenesis and continuing efforts to develop an effective microbicide against HIV infection in their talks from HIV Management 2008: The New York Course. Medscape HIV/AIDS
Review current practice, and preview possible future strategies, for management of HIV-infected patients with viral hepatitis with Drs. Chung and Thomas from HIV Management 2008: The New York Course. Medscape HIV/AIDS
Dr. Martin S. Hirsch discusses perspectives and controversies of HIV management at the 2008 HIV Management: The New York Course, held April 25-26, 2008, in New York. Medscape HIV/AIDS
Michael M. Lederman, MD, reviews our understanding of how HIV causes immune depletion, and presents a revised model of HIV pathogenesis, in his talk from HIV Management 2008: The New York Course. Medscape HIV/AIDS
Betsy C. Herold, MD, discusses developments -- and explains past failures -- in HIV microbicides in her presentation from HIV Management 2008: The New York Course. Medscape HIV/AIDS